- Report
- April 2020
- 524 Pages
France
From €5833EUR$5,995USD£4,997GBP
- Report
- April 2020
- 496 Pages
China
From €5833EUR$5,995USD£4,997GBP
- Report
- April 2020
- 341 Pages
Mexico
From €5833EUR$5,995USD£4,997GBP
- Report
- April 2020
- 345 Pages
Brazil
From €5833EUR$5,995USD£4,997GBP
The In Vitro Diagnostics (IVD) Infectious Disease market is a segment of the larger IVD industry that focuses on the diagnosis and monitoring of infectious diseases. It includes a range of products and services, such as tests for the detection of bacteria, viruses, fungi, and parasites, as well as tests for the identification of drug-resistant organisms. These tests are used to diagnose and monitor the progression of infectious diseases, as well as to guide treatment decisions.
The IVD Infectious Disease market is driven by the increasing prevalence of infectious diseases, the emergence of new and drug-resistant pathogens, and the need for rapid and accurate diagnosis. Additionally, technological advances in molecular diagnostics, such as PCR and next-generation sequencing, have enabled the development of more sensitive and specific tests.
Notable companies in the IVD Infectious Disease market include Abbott, Becton Dickinson, Roche, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more